Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessProgress Software Shares Down 3 percent on Q4 Revenue Miss

Progress Software Shares Down 3 percent on Q4 Revenue Miss

Add to Favorite
Added to Favorite


Progress Software Corporation (NASDAQ:PRGS) shares closed more than 3% lower on Wednesday after the company reported Q4 results, with revenue of $157.1 million coming in worse than the Street estimate of $161.59 million. EPS was $1.12, compared to the Street estimate of $1.09.
The company expects Q1/23 EPS to be in the range of $1.04-$1.08, compared to the Street estimate of $1.05, and revenue in the range of $156-160 million, compared to the Street estimate of $152 million.
For fiscal 2023, the company expects EPS in the range of $4.09-$4.17, compared to the Street estimate of $4.35, and revenue in the range of $671-681 million, compared to the Street estimate of $630.1 million.
According to the analysts at Oppenheimer, while fiscal 2023 guidance was underwhelming, management is being conservative due to the macro environment and there is a potential for an upside.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Canaan Inc. Gears Up for Earnings Amid Challenges

Projected earnings per share (EPS) of -$0.6 and revenue...

cbdMD, Inc. Q2 Fiscal Year 2024 Financial Results Overview

Significant revenue achievement: cbdMD reported revenue of approximately $4.38...

Ascendis Pharma Faces FDA Review Extension: Insights and Market Impact

The FDA has extended its review period for Ascendis...

Nordson Corporation Quarterly Earnings Preview

Wall Street anticipates an EPS of $2.30 and revenue...